dabigatran has been researched along with Dementia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 6 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, PS; Ho, BL; Hsieh, SW; Yang, YH | 1 |
| De Backer, TL; Grymonprez, M; Ikram, MA; Lahousse, L; Petrovic, M; Steurbaut, S | 1 |
| Bessette, LG; Bykov, K; Cervone, A; Kim, DH; Lin, KJ; Mastrorilli, JM; Singer, DE | 1 |
| Bonetti, B; Bovi, P; Bovi, T; Cappellari, M; Forlivesi, S; Micheletti, N; Musso, AM; Sajeva, G; Tomelleri, G; Valbusa, V; Zucchella, C | 1 |
| Jang, E; Joung, B; Kim, D; Kim, JY; Kim, TH; Lee, MH; Lip, GYH; Pak, HN; Sung, JH; Uhm, JS; Yang, PS; Yu, HT | 1 |
| De Souza, S; Goddard, R; Hargreaves, IP; Porter, KMF | 1 |
| Frossard, M; Koch, S; Pausch, A; Wiegele, M | 1 |
| Basalo, MC; Ferrero-Martínez, AI; Gómez-Quintanilla, A; Guitián, A; Montero-Magan, M; Olcoz-Chiva, MT; Paredes-Galán, E; Rodríguez-Artalejo, F; Rodríguez-Pascual, C; Sharma, J; Torres-Torres, I; Vilches-Moraga, A | 1 |
| Bunch, TJ; Crandall, B; Cutler, M; Day, JD; Jacobs, V; Mallender, C; May, H; Olson, J; Osborn, J; Stevens, SM; Weiss, JP; Woller, SC | 1 |
| Baumann, MR; Cabral, KP; Croft, PE; Delaney, MC; Gibbs, MA; Strout, TD | 1 |
| Bair, TL; Bunch, TJ; Crandall, BG; Cutler, MJ; Day, JD; Jacobs, V; Mallender, C; May, HT; Osborn, JS; Stevens, SM; Weiss, JP; Woller, SC | 1 |
| Messinger-Rapport, B | 1 |
3 review(s) available for dabigatran and Dementia
| Article | Year |
|---|---|
Effects of Dabigatran on Dementia Pathogenesis and Neuropsychological Function: A Review.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Dementia; Humans | 2022 |
Managing blunt trauma in patients receiving dabigatran etexilate: case study and review of the literature.
Topics: Accidental Falls; Aged; Benzimidazoles; Dabigatran; Dementia; Female; Hemorrhage; Humans; Pneumothorax; Pyridines; Rib Fractures; Spleen; Thoracostomy; Vitamin K; Wounds, Nonpenetrating | 2013 |
What's new in treating older adults?
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cholinesterase Inhibitors; Cognition; Dabigatran; Delirium; Dementia; Denosumab; Exercise; Fractures, Bone; Geriatrics; Humans; RANK Ligand; Vitamin D | 2010 |
1 trial(s) available for dabigatran and Dementia
| Article | Year |
|---|---|
Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Cognition; Cognitive Dysfunction; Dabigatran; Dementia; Female; Humans; Incidence; International Normalized Ratio; Male; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Treatment Outcome; Warfarin | 2019 |
8 other study(ies) available for dabigatran and Dementia
| Article | Year |
|---|---|
Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort study.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Belgium; Cohort Studies; Dabigatran; Dementia; Humans; Rivaroxaban; Stroke | 2023 |
Comparative Effectiveness and Safety of Oral Anticoagulants by Dementia Status in Older Patients With Atrial Fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Comparative Effectiveness Research; Dabigatran; Dementia; Female; Hemorrhage; Humans; Ischemic Stroke; Male; Medicare; Retrospective Studies; Rivaroxaban; United States; Warfarin | 2023 |
Factors influencing cognitive performance after 1-year treatment with direct oral anticoagulant in patients with atrial fibrillation and previous ischemic stroke: a pilot study.
Topics: Aged; Atrial Fibrillation; Cognition; Dabigatran; Dementia; Duration of Therapy; Factor Xa Inhibitors; Female; Heart Failure; Humans; Hyperlipidemias; Ischemic Stroke; Italy; Male; Myocardial Ischemia; Neuropsychological Tests; Prognosis; Risk Factors | 2021 |
Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Dementia; Female; Humans; Male; Pyridones; Rivaroxaban; Stroke | 2021 |
Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD).
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Dementia; Humans; Pyrazoles; Pyridones; Rivaroxaban | 2021 |
The diagnostic challenge of a vitamin K antagonist with dabigatran use triggering massive intracranial haemorrhage.
Topics: Aged, 80 and over; Anticoagulants; Dabigatran; Dementia; Drug Overdose; Fatal Outcome; Humans; Intracranial Hemorrhages; Male; Multiple Organ Failure; Skull Fractures; Vitamin K | 2017 |
Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Oldest Old Patients: A Prospective Study.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Chronic Disease; Comorbidity; Dabigatran; Dementia; Dicumarol; Disabled Persons; Follow-Up Studies; Hemorrhage; Humans; Mobility Limitation; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Vitamin K | 2018 |
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Dementia; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Mortality; Multivariate Analysis; Propensity Score; Proportional Hazards Models; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Warfarin | 2016 |